The effect of anti-reactional drugs on complement components in the type II, erythema nodosum leprosum, reaction
- 31 July 1988
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 119 (2) , 255-258
- https://doi.org/10.1111/j.1365-2133.1988.tb03209.x
Abstract
Seventeen patients with the type II (erythema nodosum leprosum) (ENL) reaction were studied. They received multidrug therapy and also the anti-reactional drugs prednisolone clofazimine or chloroquin, and we measured serum levels of complement components before treatment and after the reaction had subsided. Factor B was significantly elevated after treatment with each of the three drugs. C3 levels were significantly increased after treatment, the largest change being in patients treated with clofazimine. In these patients there was also a concomitant decrease in C3d levels. This suggests that clofazimine has complement modulating activity and we would recommend it as the drug of choice in treatment of the ENL reaction.This publication has 5 references indexed in Scilit:
- Contemplative Immune Mechanism of Lucio Phenomenon and Its Global StatusThe Journal of Dermatology, 1987
- Reactions in Leprosy Clinical AspectsInternational Journal of Dermatology, 1987
- CORRELATION OF MORPHOLOGICAL, BACTERIOLOGICAL, HISTOPATHOLOGICAL AND IMMUNOLOGICAL FEATURE OF LEPROSYThe Journal of Dermatology, 1985
- Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.Journal of Clinical Investigation, 1975
- Immunochemical quantitation of antigens by single radial immunodiffusionMolecular Immunology, 1965